Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK consultation on PGD (pre-implantation genetic diagnosis) moves forward:

This article was originally published in Clinica

Executive Summary

The next step in the UK's parliamentary consultation on pre-implantation genetic diagnosis (PGD) will be its fifth oral evidence session, on September 8. The House of Commons Science and Technology Committee will take evidence from seven experts, including: Linda Ball, Muscular Dystrophy Association; Peter and Fiona Hingston, Cystic Fibrosis Trust; Dr Simon Fishel, director of Centres for Assisted Reproduction (CARE); Professor Peter Braude, of Guys, Kings and St Thomas' School of Medicine; and Professor Tom Baldwin, chairman of the Ethics & Law Committee of the HFEA.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT059439

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel